Headlines
Bloomberg MarketsIntesa Plans to Start Monte Paschi Bid in Last Week of NovemberBloomberg MarketsUS Stock Futures Rise as Oil Prices Drop Easing AI-Led SelloffBloomberg MarketsWall Street Escalates FinTwit Crackdown as AI Copycat Fears GrowFinancial TimesAlstom shares tumble 28% after train maker cuts profit forecastFinancial TimesHow Putin has split the westBloomberg MarketsOracle Seeks to Raise $10 Billion in Return to Bond MarketFinancial TimesMarvell to buy data centre component maker Lumentum in $115bn AI betBloomberg MarketsFed May Need 4 or 5 Rate Hikes in Total , Economist Dutta SaysBloomberg MarketsMarriott Beats as US Demand Helps Boost Outlook; Shares RiseFinancial TimesGlobal AI sell-off eases after Nasdaq’s worst month in over a yearBloomberg MarketsData Center Restrictions Make the Ballot in Dozens of US CitiesBloomberg MarketsCash-Strapped LNG Buyers Like Bangladesh Are at Breaking PointFinancial TimesNetanyahu presses Trump for renewed strikes against IranBloomberg MarketsRomania Is Offering Eurobonds After New Government Takes OfficeBloomberg MarketsTrump Says He May Become ‘Mr. Veto’ if Democrats Win MidtermsBloomberg MarketsIntesa Plans to Start Monte Paschi Bid in Last Week of NovemberBloomberg MarketsUS Stock Futures Rise as Oil Prices Drop Easing AI-Led SelloffBloomberg MarketsWall Street Escalates FinTwit Crackdown as AI Copycat Fears GrowFinancial TimesAlstom shares tumble 28% after train maker cuts profit forecastFinancial TimesHow Putin has split the westBloomberg MarketsOracle Seeks to Raise $10 Billion in Return to Bond MarketFinancial TimesMarvell to buy data centre component maker Lumentum in $115bn AI betBloomberg MarketsFed May Need 4 or 5 Rate Hikes in Total , Economist Dutta SaysBloomberg MarketsMarriott Beats as US Demand Helps Boost Outlook; Shares RiseFinancial TimesGlobal AI sell-off eases after Nasdaq’s worst month in over a yearBloomberg MarketsData Center Restrictions Make the Ballot in Dozens of US CitiesBloomberg MarketsCash-Strapped LNG Buyers Like Bangladesh Are at Breaking PointFinancial TimesNetanyahu presses Trump for renewed strikes against IranBloomberg MarketsRomania Is Offering Eurobonds After New Government Takes OfficeBloomberg MarketsTrump Says He May Become ‘Mr. Veto’ if Democrats Win Midterms
Home/Marginal Revolution
Back
MARKETS:
SPY+0.26%
DIA+0.23%
QQQ-0.14%
IWM+0.29%
GLD-0.40%
USO+1.64%
Marginal Revolutionanalysis

Expensive Pharmaceuticals for Targeted Diseases

Marginal Revolution
Monday, November 2, 2026 at 12:16 PM
~4 min read
Inflation

Original Report

My latest paper, The Price of a Cure: Luxturna and the Economic Dilemmas of Precision Medicine, is in the Journal of Law, Medicine and Ethics. I discuss the economics of the pharmaceutical industry...

My latest paper, The Price of a Cure: Luxturna and the Economic Dilemmas of Precision Medicine, is in the Journal of Law, Medicine and Ethics. I discuss the economics of the pharmaceutical industry and the special issues that arise with targeted drugs that cure. We are going to get many more of these drugs in […] The post Expensive Pharmaceuticals for Targeted Diseases appeared first on Marginal REVOLUTION.

Glass House Analysis

Inflation is the silent tax that erodes purchasing power, hitting hardest those who can least afford it. When grocery bills rise faster than wages, families face impossible choices between food, medicine, and rent. Unlike market volatility that mainly affects investors, inflation touches everyone who buys groceries, fills a gas tank, or pays rent.

The implications extend beyond the immediate news cycle. Every economic development creates ripples that affect employment, prices, and opportunities in ways that may not be immediately visible but are deeply felt. By tracking these connections, we can better understand how the economy truly works—not as an abstract machine, but as a human system shaped by and shaping the lives of millions.

Enjoyed this analysis?

Get the Glass House Briefing every morning—market news that actually makes sense, delivered free to your inbox.

No spam. Unsubscribe anytime.

More Stories

Economic Context

S&P 500
+0.26%
Dow Jones
+0.23%
NASDAQ 100
-0.14%
Russell 2000
+0.29%